Pandya, Rushika
He, Yudong D.
Sweeney, Timothy E.
Hasin-Brumshtein, Yehudit
Khatri, Purvesh https://orcid.org/0000-0002-4143-4708
Funding for this research was provided by:
Inflammatix, Inc.
Article History
Received: 7 March 2023
Accepted: 27 July 2023
First Online: 28 August 2023
Declarations
:
: The present study is a meta-analysis that utilized publicly available data and did not involve the recruitment of any new human subjects. The data used was previously collected as described by the original studies and is fully anonymized. Our research approach and methodology adhered strictly to the principles of the Declaration of Helsinki as they pertain to the ethical conduct of research involving human subjects.
: Not applicable.
: R.P., Y.H.B., Y.D.H., and T.E.S. are employees of and/or stockholders of Inflammatix, Inc. P.K. is a stockholder of Inflammatix, Inc., and participated in this work as a consultant. Inflammatix is a for-profit company focusing on the development and commercialization of best-in-class host-response diagnostic tests.